Skip to main content
Log in

Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The effect of suppression with antimicrobial agents of the intestinal microflora of paediatric bone marrow graft recipients on severe bacterial and fungal infections and on moderate to severe acute graft-versus-host disease was studied retrospectively. Data on 65 cases of bone marrow transplantation for either severe bone marrow failure or leukaemia, performed in a strict protective environment with either complete or selective gastrointestinal decontamination, were evaluated. All bone marrow grafts were from HLA-identical siblings and were not depleted of T-lymphocytes. Twenty percent of the recipients had one or more episodes of septicaemia during the granulocytopenic period after transplantation, mostly due to gram-positive bacteria. Only five children died due to infection, in each case caused by a microorganism originating from the endogenous flora. Complete gastrointestinal decontamination was superior to selective gastrointestinal decontamination in preventing infectious complications (p<0.001). The same was the case for the prevention of acute graft-versus-host disease of grade II or higher, which was observed in 7 of 40 (17.5 %) completely decontaminated children versus 9 of 18 (50 %) selectively decontaminated children evaluable for graft-versus-host disease (p<0.01). It is concluded that complete gastrointestinal decontamination in a strict protective environment is a feasible and very effective method for preventing severe infections and acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents; it resulted in a low transplantation-related mortality of 26 % and a good quality of survival in 69 % of the graft recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Meyers JD, Atkinson JD Infection in bone marrow transplantation. Clinics in Hematology 1983, 12: 791–811.

    Google Scholar 

  2. Tutschka PJ Infections and immunodeficiency in bone marrow transplantation. Pediatric Infectious Disease Journal 1988, 7, Supplement: 22–29.

    Google Scholar 

  3. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffmann RG, Kay HEM, Kersey JH, Marmont A, Masaoka T, Rimm A, van Rood JJ, Zwaan FE Risk factors for acute graft-versus-host disease. British Journal of Haematology 1987, 67: 397–406.

    PubMed  Google Scholar 

  4. Sullivan KM, Witherspoon R, Deeg HJ, Doney K, Appelbaum F, Sanders J, Lum L, Loughran T, Hill R, Anasetti C, Shields A, Nims J, Shulman H, Storb R, Thomas ED Chronic graft-versus-host disease in man. In: Gale RP, Champlin R (ed): Progress in bone marrow transplantation. Alan R. Liss, New York, 1987, p. 473–487.

    Google Scholar 

  5. Levitan AA, Perry S The use of an isolator system in cancer chemotherapy. American Journal of Medicine 1968, 44: 234–242.

    Article  PubMed  Google Scholar 

  6. Yates JW, Holland JF A controlled study on isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer 1973, 32: 1490–1498.

    PubMed  Google Scholar 

  7. Levine AS, Siegel SE, Schreiber AD, Hauser J, Preisler H, Goldstein F, Seidler F, Simon R, Perry S, Bennet JE, Henderson ES Protected environments and prophylactic antibiotics. A prospective controlled study on their utility in the therapy of acute leukemia. New England Journal of Medicine 1973, 288: 477–483.

    PubMed  Google Scholar 

  8. Klastersky J, Debuscher L, Weerts D, Daneau D Use of oral antibiotics in protected environment units: clinical effectiveness and role in the emergence of antibiotic-resistant strains. Pathologie Biologie 1974, 22: 5–12.

    PubMed  Google Scholar 

  9. Schimpff SC, Greene WH, Young VM, Forner CL, Hepsen L, Cusack N, Block JB, Wiernik PH Infection prevention in acute nonlymphocytic leukemia. Laminar air flow reverse isolation with oral, non-absorbable antibiotic prophylaxis. Annals of Internal Medicine 1975, 82: 351–358.

    PubMed  Google Scholar 

  10. Fopp M, Gasse A, Eigenmann B, Jungi WF, Meuret G, Senn HJ Infektionprophylaxe bei Patienten mit Agranulocytose durch Isolation und Ganzkörperdekontamination. Schweizerische Medizinische Wochenschrift 1975, 105: 1123–1125.

    PubMed  Google Scholar 

  11. Dietrich M, Gaus W, Vossen J, van der Waaij D, Wendt F Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. I: Clinical results. Infection 1977, 5: 107–114.

    Article  PubMed  Google Scholar 

  12. Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT, Thomas ED, andThe Seattle Marrow Transplant Team Protective environment for marrow transplant recipients. A prospective study. Annals of Internal Medicine 1978, 89: 893–901.

    PubMed  Google Scholar 

  13. Kurrle E, Bhaduri S, Heimpel H, Hoelzer D, Krieger D, Vanek E, Kubanek B The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukaemia. Blut 1980, 40: 187–195.

    Article  PubMed  Google Scholar 

  14. Jones JM, Wilson R, Bealmear PM Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiation Research 1971, 45: 577–588.

    PubMed  Google Scholar 

  15. Heit H, Wilson R, Fliedner TM, Kohne E Mortality of secondary disease in antibiotic treated mouse radiation chimeras. In: Heneghan JB (ed): Germfree research. Biological effect of gnotobiotic environments. Academic Press, New York, 1973, p. 477–483.

    Google Scholar 

  16. Truit RL Application of germfree techniques to the treatment of leukemia in AKR mice by allogeneic bone marrow transplantation. In: Waters H (ed): The handbook of cancer immunology. Volume 5: Immunotherapy. Garland STPM Press, New York, 1978, p. 431–452.

    Google Scholar 

  17. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. Journal of the National Cancer Institute 1974, 52: 401–404.

    PubMed  Google Scholar 

  18. Wagemaker G, Heidt PJ, Merchav S, van Bekkum DW Abrogation of histocompatibility barriers to bone marrow transplantation in rhesus monkeys. In: Baum SD, Ledney GD, Thierfelder S (ed): Experimental hematology today. Karger, Basel, 1982, p. 111–118.

    Google Scholar 

  19. Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. New England Journal of Medicine 1983, 308: 302–307.

    PubMed  Google Scholar 

  20. Mahmoud HK, Schaefer UW, Schüning F, Schmidt CG, Bamberg M, Haralambie E, Linzenmeier G, Hantschke D, Grosse-Wilde H, Luboldt W, Richter HJ Laminar air flow versus barrier nursing in marrow transplant recipients. Blut 1984, 49: 375–381.

    Article  PubMed  Google Scholar 

  21. Schmeiser T, Kurrle E, Arnold R, Heit W, Krieger D, Kubanek B, Heimpel H Application of antimicrobial prophylactic treatment to the prevention of infection and graft-versus-host disease in allogeneic bone marrow transplantation. Experimental Hematology 1984, 12, Supplement 15: 105–106.

    Google Scholar 

  22. Storb R, Thomas ED Graft-versus-host disease in dog and man: the Seattle experience. Immunological Reviews 1985, 88: 215–238.

    PubMed  Google Scholar 

  23. Leblond V, Belanger C, Dreyfus F, Brunet F, Gabarre J, Asselain B, Binet L Interest of laminar air flow for prevention of GvHD and infections in BMT for leukaemia and lymphoma. Bone Marrow Transplantation 1987, 2, Supplement 1: 181.

    Google Scholar 

  24. Skinhøj P, Jacobsen N, Høiby N, Faber V, and the Copenhagen Bone Marrow Transplant Group Strict protective isolation in allogeneic bone marrow transplantation: effect on infectious complications, fever and graft versus host disease. Scandinavian Journal of Infectious Diseases 1987, 19: 91–96.

    PubMed  Google Scholar 

  25. Vossen JM, Heidt PJ, Guiot HFL, Dooren LJ Prevention of acute graft versus host disease in clinical bone marrow transplantation: complete versus selective intestinal decontamination. In: Sasaki S, Ozawa A, Hashimoto K (ed): Recent advances in germfree research. Tokai University Press, Tokyo, 1981, p. 573–577.

    Google Scholar 

  26. Storb R, Epstein RB, Graham TC, Thomas ED Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970, 9: 240–246.

    PubMed  Google Scholar 

  27. van der Waaij D, Vossen JM, Korthals-Altes C Patient isolators designed in the Netherlands. In: Heneghan JB (ed): Germfree research. Biological effect of gnotobiotic environment. Academic Press, New York, 1973, p. 31–36.

    Google Scholar 

  28. van Bekkum DW Bone marrow transplantation. Transplantation Proceedings 1977, 9: 147–154.

    Google Scholar 

  29. Vossen JM, van der Waaij D Recolonization after decontamination: Clinical experiences. In: Hers JFP, Winkler KC (ed): Airborne transmission and airborne infection. Oosthoek, Utrecht, 1973, p. 549–553.

    Google Scholar 

  30. van der Waaij D, Vossen JM, Korthals-Altes C, Hartgrink C Reconventionalization following antibiotic decontamination in man and animals. American Journal of Clinical Nutrition 1977, 30: 1887–1895.

    PubMed  Google Scholar 

  31. Heidt PJ, van der Waaij D, Vossen JM, Hendriks WDH Recontamination following antibiotic decontamination: Restoration of colonization resistance. Microecology and Therapy 1981, 11: 71–82.

    Google Scholar 

  32. Guiot HFL, Biemond J, Klasen E, Gratama JW, Kramps JA, Zwaan FE Protein loss during acute graft-versus-host disease: diagnostic and clinical significance. European Journal of Haematology 1987, 38: 187–196.

    PubMed  Google Scholar 

  33. Thomas ED, Storb R, Clift RA, Fever A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD Bone marrow transplantation. New England Journal of Medicine 1975, 292: 895–902.

    PubMed  Google Scholar 

  34. Rodrigues V, Bodey GP, Freireich EJ, McCredie KB, Gutterman JU, Keating MJ, Smith TL, Gehan EA Randomized trial of protected environment-prophylactic antibiotics in 145 adults with acute leukemia. Medicine 1978, 57: 253–266.

    PubMed  Google Scholar 

  35. Clift RA, Buckner CD, Thomas ED Gnotobiology in bone marrow transplantation. In: Fliedner T, Heit H, Niethammer D and Pflieger H (ed): Clinical and experimental gnotobiotics. Gustav Fischer Verlag, Stuttgart, 1979, p. 255–264.

    Google Scholar 

  36. Winston DJ, Gale RP, Meyer DV, Young LS Infectious complications of human bone marrow transplantation. Medicine 1979, 58: 1–31.

    PubMed  Google Scholar 

  37. Watson JG, Powles RL, Lawson DN, Morgenstern GR, Jameson B, McElwain TJ, Judson I, Lumley H Co-trimoxazole versus non-absorbable antibiotics in acute leukemia. Lancet 1982, ii: 6–9.

    Article  Google Scholar 

  38. Navari RM, Buckner CD, Clift RA, Storb R, Sanders J, Stewart P, Sullivan KM, Williams B, Counts GW, Meyers JD, Thomas ED Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. American Journal of Medicine 1984, 76: 564–572.

    Article  PubMed  Google Scholar 

  39. van der Meer JWM, Guiot HFL, van den Broek PJ, van Furth R Infections in bone marrow transplant recipients. Seminars in Hematology 1984, 21: 123–140.

    PubMed  Google Scholar 

  40. Winston DJ, Ho WG, Champlin RE, Gale RD Infectious complications of bone marrow transplantation. Experimental Hematology 1984, 12: 205–215.

    PubMed  Google Scholar 

  41. Henslee J. Bostrom B, Weisdorf D, Ramsay N, McGlave P, Kersey J Streptococcal sepsis in bone marrow transplant patients. Lancet 1984, i: 393.

    Article  Google Scholar 

  42. Groot-Loonen JJ, van der Noordaa J, de Kraker J, Voûte PA, van Lecuwen EF, Terpstra WJ, Ansink-Schipper MC Alpha-hemolytic streptococcal septicemia with severe complications during neutropenia in childhood cancer. Pediatric Hematology and Oncology 1987, 4: 323–328.

    PubMed  Google Scholar 

  43. Heidt PJ Gnotobiotics and bone marrow transplantation: experimental and clinical studies. Radiobiological Institute of the Division for Health Research TNO, Rijswijk, The Netherlands, 1989, p. 21–37.

    Google Scholar 

  44. Storb R, Deeg JH, Fisher L, Appelbaum F, Buckner CD, Bensinger W, Clift R, Doney K, Irle C, McGuffin R, Martin P, Sanders J, Schoch G, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas DE Cyclosporine versus methotrexate for graftversus-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood 1988, 71: 293–298.

    PubMed  Google Scholar 

  45. Horowitz MM, for the Writing Committee:Atkinson K, van Bekkum DW, Bortin MM, Gluckman E, Gale RP, Good RA, Jacobson N, Kolb HJ, Rimm AA, Ringden O, Rozman C, Zwaan FE Risk factors for chronic graft-versus-host disease: a preliminary report from the International Bone Marrow Transplant Registry. Bone Marrow Transplantation 1987, 2, Supplement 1: 215.

    Google Scholar 

  46. Vriesendorp HM, Heidt PJ, Zurcher C Gastrointestinal decontamination of dogs treated with total body irradiation and bone marrow transplantation. Experimental Hematology 1981, 9: 904–916.

    PubMed  Google Scholar 

  47. Heidt PJ Gnotobiotics and bone marrow transplantation: experimental and clinical studies. Radiobiological Institute of the Division for Health Research TNO, Rijswijk, The Netherlands, 1989, p. 74–93.

    Google Scholar 

  48. Heidt PJ, Timmermans CPJ, van den Hout Y, Vossen JM Endotoxin concentrations in the faeces of completely and selectively decontaminated children treated with bone marrow transplantation for leukaemia or severe aplastic anaemia. In: Gnotobiology and its applications. Fondation Marcel Mérieux, Lyon, 1988, p. 178–180.

    Google Scholar 

  49. Kamphuis RP Psychological and ethical considerations in the use of germfree treatment. In: Fliedner T, Heit H, Niethammer D, Pflieger H (ed): Clinical and experimental gnotobiotics. Gustav Fischer Verlag, Stuttgart, 1979, p. 53–60.

    Google Scholar 

  50. Kamphuis RP Late effects of a bone marrow transplantation or chemotherapy on the social adaptation and personality of adolescents with haemato-oncological diseases. Bone Marrow Transplantation 1988, 3, Supplement 1: 289.

    Google Scholar 

  51. Engelhard D, Marks MI, Good RA Infections in bone marrow transplant recipients. Journal of Pediatrics 1986, 108: 335–346.

    PubMed  Google Scholar 

  52. Engel GL, Bergman E, Mistiaen P: Costs-effectiveness analysis of bone marrow transplantation. Report of the Health Council of The Netherlands, 1987/17.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vossen, J.M., Heidt, P.J., van den Berg, H. et al. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur. J. Clin. Microbiol. Infect. Dis. 9, 14–23 (1990). https://doi.org/10.1007/BF01969527

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01969527

Keywords

Navigation